Skip to content Provide accessibility feedback
For Providers
For Patients
Customer Stories
About Us
Contact Us
Magnifying glass Search

Volpara has entered into a Scheme Implementation Agreement with Lunit, Inc.

Confident decision making for efficient breast screening

The most scientifically validated screening software in the breast health industry. Volpara gives you the evidence you need, right when you need it. Access to patient data for more informed breast cancer risk assessment.

1
Trusted insight

Volpara Health is the preferred partner of leading clinical sites, including  top cancer centers.  

2
Continuous improvement

Each and every image we analyze improves our algorithms for early detection of breast cancer.  

3
Precise intelligence

Artificial intelligence grounded in science to enhance clinician expertise.

4
Medical necessity

Your aid in advocating for additional screening or genetic testing of patients.

400+

Peer-reviewed papers and research abstracts featuring Volpara

2,000+

Mammography facilities use Volpara software

The only

Volumetric breast density assessment validated for use with Tyrer-Cuzick 8

Breast health software

AI-powered software to optimize breast imaging

Volpara Patient Hub

Patient Hub

Speed your workflow with customizable patient reporting and communications.

Volpara Scorecard

Scorecard

View patient risk insights essential for early detection.

Volpara Risk

Risk Pathways

A full program for identifying, tracking, and managing high-risk patients.

Last year we did 51,000 mammograms. When you’re always reading more it needs to be easier—not harder. Volpara has made a big difference.

– Cathrine Keller, MD, President, Lake Medical Imaging

Explore

You might be interested in...

News
15 Feb 2022

Volpara Health secures US patent focused on detection of breast arterial calcifications via mammograms

News
29 Nov 2021

Volpara Health Showcases Enhancements to Its Integrated Breast Platform at RSNA